These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

497 related items for PubMed ID: 17306417

  • 1. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety.
    Lowe NJ, Glaser DA, Eadie N, Daggett S, Kowalski JW, Lai PY, North American Botox in Primary Axillary Hyperhidrosis Clinical Study Group.
    J Am Acad Dermatol; 2007 Apr; 56(4):604-11. PubMed ID: 17306417
    [Abstract] [Full Text] [Related]

  • 2. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 3. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.
    Naumann M, Lowe NJ, Kumar CR, Hamm H, Hyperhidrosis Clinical Investigators Group.
    Arch Dermatol; 2003 Jun; 139(6):731-6. PubMed ID: 12810503
    [Abstract] [Full Text] [Related]

  • 4. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM, BOTOX North American Episodic Migraine Study Group.
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [Abstract] [Full Text] [Related]

  • 5. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
    Vadoud-Seyedi J, Simonart T.
    Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
    [Abstract] [Full Text] [Related]

  • 6. Low-dose efficacy of botulinum toxin A for axillary hyperhidrosis: a randomized, side-by-side, open-label study.
    Heckmann M, Plewig G, Hyperhidrosis Study Group.
    Arch Dermatol; 2005 Oct; 141(10):1255-9. PubMed ID: 16230563
    [Abstract] [Full Text] [Related]

  • 7. A double-blind, randomized, placebo-controlled comparison of botulinum toxin type a injection sites and doses in the prevention of episodic migraine.
    Saper JR, Mathew NT, Loder EW, DeGryse R, VanDenburgh AM, BoNTA-009 Study Group.
    Pain Med; 2007 Sep; 8(6):478-85. PubMed ID: 17716321
    [Abstract] [Full Text] [Related]

  • 8. Durability of botulinum toxin treatment for axillary hyperhidrosis.
    Moffat CE, Hayes WG, Nyamekye IK.
    Eur J Vasc Endovasc Surg; 2009 Aug; 38(2):188-91. PubMed ID: 19395290
    [Abstract] [Full Text] [Related]

  • 9. Botulinum toxin A for axillary hyperhidrosis (excessive sweating).
    Heckmann M, Ceballos-Baumann AO, Plewig G, Hyperhidrosis Study Group.
    N Engl J Med; 2001 Feb 15; 344(7):488-93. PubMed ID: 11172190
    [Abstract] [Full Text] [Related]

  • 10. Diode laser hair removal does not interfere with botulinum toxin A treatment against axillary hyperhidrosis.
    Paul A, Kranz G, Schindl A, Kranz GS, Auff E, Sycha T.
    Lasers Surg Med; 2010 Mar 15; 42(3):211-4. PubMed ID: 20333738
    [Abstract] [Full Text] [Related]

  • 11. Prospective open-label study of botulinum toxin type A in patients with axillary hyperhidrosis: effects on functional impairment and quality of life.
    Solish N, Benohanian A, Kowalski JW, Canadian Dermatology Study Group on Health-Related Quality of Life in Primary Axillary Hyperhidrosis.
    Dermatol Surg; 2005 Apr 15; 31(4):405-13. PubMed ID: 15871315
    [Abstract] [Full Text] [Related]

  • 12. Botulinum toxin type a versus topical 20% aluminum chloride for the treatment of moderate to severe primary focal axillary hyperhidrosis.
    Flanagan KH, King R, Glaser DA.
    J Drugs Dermatol; 2008 Mar 15; 7(3):221-7. PubMed ID: 18380203
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of botulinum toxin type A in the treatment of focal axillary hyperhidrosis.
    Absar MS, Onwudike M.
    Dermatol Surg; 2008 Jun 15; 34(6):751-5. PubMed ID: 18318723
    [Abstract] [Full Text] [Related]

  • 14. A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches.
    Relja M, Poole AC, Schoenen J, Pascual J, Lei X, Thompson C, European BoNTA Headache Study Group.
    Cephalalgia; 2007 Jun 15; 27(6):492-503. PubMed ID: 17428299
    [Abstract] [Full Text] [Related]

  • 15. A double-blind, randomized, comparative study of two type A botulinum toxins in the treatment of primary axillary hyperhidrosis.
    Talarico-Filho S, Mendonça DO Nascimento M, Sperandeo DE Macedo F, DE Sanctis Pecora C.
    Dermatol Surg; 2007 Jan 15; 33(1 Spec No.):S44-50. PubMed ID: 17241414
    [Abstract] [Full Text] [Related]

  • 16. Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis.
    Baumann L, Slezinger A, Halem M, Vujevich J, Martin LK, Black L, Bryde J.
    Int J Dermatol; 2005 May 15; 44(5):418-24. PubMed ID: 15869543
    [Abstract] [Full Text] [Related]

  • 17. Botulinum toxin type A and divalproex sodium for prophylactic treatment of episodic or chronic migraine.
    Blumenfeld AM, Schim JD, Chippendale TJ.
    Headache; 2008 Feb 15; 48(2):210-20. PubMed ID: 18047502
    [Abstract] [Full Text] [Related]

  • 18. Botulinum toxin A improves the quality of life of patients with neurogenic urinary incontinence.
    Schurch B, Denys P, Kozma CM, Reese PR, Slaton T, Barron RL.
    Eur Urol; 2007 Sep 15; 52(3):850-8. PubMed ID: 17467889
    [Abstract] [Full Text] [Related]

  • 19. [Efficacy of botulinum toxin A in the treatment of axillary and palmar hyperhidrosis: 10 cases].
    Maillard H, Briand N, Bara C, Celerier P.
    Ann Dermatol Venereol; 2003 May 15; 130(5):511-3. PubMed ID: 12843826
    [Abstract] [Full Text] [Related]

  • 20. Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study.
    Güleç AT.
    J Eur Acad Dermatol Venereol; 2012 Mar 15; 26(3):314-8. PubMed ID: 21492253
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.